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Abstract 31 
Whole genome sequencing (WGS) was used for the characterization of the, frequently 32 
extensively-drug resistant (XDR), P. aeruginosa high-risk clone ST175. A total of 33 
eighteen ST175 isolates recovered from 8 different Spanish hospitals were analyzed; 34 
four isolates from four different French hospitals were included for comparison. The 35 
typical resistance profile of ST175 included penicillins, cephalosporins, monobactams, 36 
carbapenems, aminoglycosides, and fluoroquinolones. In the phylogenetic analysis, the 37 
four French isolates clustered together with the two isolates from one of the Spanish 38 
regions. Sequence variation was analyzed for 146 chromosomal genes related to 39 
antimicrobial resistance and horizontally-acquired genes were explored using online 40 
databases. The resistome of ST175 was mainly determined by mutational events, with 41 
resistance traits common to all or nearly all of the strains, including specific ampR 42 
mutations leading to ampC overexpression, specific mutations in oprD conferring 43 
carbapenem resistance or a mexZ mutation leading to MexXY overexpression. All 44 
isolates additionally harbored an aadB gene conferring gentamicin and tobramycin 45 
resistance. Several other resistance traits were specific to certain geographic areas such 46 
as a streptomycin resistance aadA13 gene detected in all four isolates from France and 47 
in the 2 isolates from the Cantabria region or a glpT mutation conferring fosfomycin 48 
resistance detected in all but these six isolates. Finally, several unique resistance 49 
mutations were detected in single isolates; particularly interesting among them were 50 
those in genes encoding PBPs (PBP1A, PBP3 and PBP4). Thus, these results provide 51 
valuable information for understanding the genetic basis of resistance and the dynamics 52 
of dissemination and evolution of high-risk clones. 53 
54 
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 55 
Introduction 56 
Pseudomonas aeruginosa, a ubiquitous microorganism, is one of the most 57 
relevant pathogens causing human opportunistic infections (1). Due to its impressive 58 
metabolic plasticity and versatility, P. aeruginosa is capable of infecting/colonizing a 59 
wide range of ecological niches, including aquatic and soil habitats, animals and plants 60 
(2). P. aeruginosa is one of the most frequent and severe causes of acute nosocomial 61 
infections, particularly affecting immunocompromised (especially neutropenic) patients 62 
or those admitted to the Intensive Care Unit (ICU). Indeed, P. aeruginosa is the number 63 
one pathogen causing ventilator associated pneumonia (VAP) and burn wound 64 
infections, both associated with a very high (>30%) mortality rate (3). Likewise, P. 65 
aeruginosa is the most frequent and severe driver of chronic respiratory infections in 66 
patients suffering from cystic fibrosis (CF) or other chronic underlying diseases such as 67 
bronchiectasis and chronic obstructive pulmonary disease (COPD) (4).  68 
The increasing prevalence of nosocomial infections produced by multidrug-69 
resistant (MDR) or extensively drug-resistant (XDR) P. aeruginosa strains severely 70 
compromises the selection of appropriate treatments and is therefore associated with 71 
significant morbidity and mortality (5, 6). This growing threat results from the 72 
extraordinary capacity of this pathogen for developing resistance to nearly all available 73 
antibiotics by the selection of mutations in chromosomal genes and from the increasing 74 
prevalence of transferable resistance determinants, particularly those encoding class B 75 
carbapenemases (metallo-β-lactamases [MBLs]) or extended-spectrum β-lactamases 76 
(ESBLs), frequently cotransferred with genes encoding aminoglycoside-modifying 77 
enzymes (7, 8, 9).  78 
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The global success of bacterial pathogens is expected to be determined by a 79 
complex interplay between fitness, pathogenicity, epidemicity, and antibiotic resistance 80 
(10-15). For decades, multiple reports have warned of the occurrence of epidemic 81 
outbreaks caused by MDR/XDR strains within the hospital environment. More recently, 82 
concerning reports have provided evidence of the existence of MDR/XDR global clones 83 
disseminated in several hospitals worldwide that have been denominated high-risk 84 
clones (16, 17). One such clone is ST175, widely distributed in multiple European 85 
countries, especially Spain and France (18, 19, 20, 21). Some of the genetic markers 86 
responsible of the MDR/XDR profile of this clone have been delineated through Sanger 87 
sequencing in some ST175 isolates from a Spanish multicenter study of bloodstream 88 
infections (18). In this work, we used whole genome sequencing (WGS) for the 89 
characterization of the phylogeny and the resistome of this major clone, defining 90 
common and variable resistance traits, using for this purpose a collection of isolates 91 
recovered from 8 different Spanish hospitals as well as French isolates for comparative 92 
purposes.     93 
94 
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Materials and methods 95 
 Bacterial strains, molecular typing, and susceptibility testing. A total of 14 96 
ST175 P. aeruginosa isolates recovered from bloodstream infections in a 2008-2009 97 
multicenter study in Spain were studied (18, 22). The isolates selected included up to 98 
two ST175 representatives per each of the 10 hospitals participating in the multicenter 99 
study. Since ST175 was detected in 8 of the 10 hospitals (from 4 different geographic 100 
regions: Catalonia, Cantabria, Andalusia and Balearic Islands), and two of them 101 
provided only one case, the collection studied included 14 isolates. Additionally, 4 102 
isolates recovered from bloodstream infections in one of the hospitals (Hospital Son 103 
Espases, Balearic Islands) six years later (2015) were included for comparative 104 
purposes. Likewise, 4 ST175 isolates recovered from hospitals in 4 different French 105 
cities in 2010 were included for comparison. The MICs of ceftazidime, cefepime, 106 
aztreonam, piperacillin-tazobactam, imipenem, meropenem, gentamicin, tobramycin, 107 
amikacin, levofloxacin, ciprofloxacin, colistin and fosfomycin were determined by 108 
broth microdilution according to CLSI guidelines and breakpoints (23). When needed, 109 
sequence types were determined by Multilocus Sequence Typing (MLST) analysis 110 
according to previously described protocols (24). 111 
Characterization of resistance mechanisms. The presence of horizontally-112 
acquired β-lactamases was ruled out through previously established phenotypic and 113 
molecular (PCR) methods (18). The expression of the genes encoding the chromosomal 114 
β-lactamase AmpC (ampC) and four P. aeruginosa efflux pumps, MexAB-OprM 115 
(mexB), MexCD-OprJ (mexD), MexEF-OprN (mexF), and MexXY-OprM (mexY), were 116 
determined from late-log-phase Luria-Bertani (LB) broth cultures at 37ºC and 180 rpm 117 
by real-time reverse transcription-PCR (RT-PCR) with an Illumina (Eco Real-Time 118 
PCR System), as previously described (25). When needed, the sequence of genes 119 
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involved in antibiotic resistance was confirmed through PCR amplification followed by 120 
Sanger sequencing using previously described protocols (25).  121 
 Library preparation and whole genome sequencing. Genomic DNA was 122 
isolated by the use of a commercial capture system (High Pure PCR Template 123 
Preparation Kit, Roche diagnostics) and indexed paired-end libraries were generated by 124 
using a commercial library preparation kit (NexteraXT DNA Library Preparation Kit, 125 
Illumina). Libraries were then sequenced on an Illumina MiSeq® bench-top sequencer 126 
with MiSeq reagent kit v2 (Illumina Inc., USA), generating 250-bp paired-end reads and 127 
using a multiplexed protocol (to obtain an average of 195.595 reads (range of 49.923-128 
518.714) per isolate).  129 
 Variant calling. Each isolate reads were mapped against the genome of the P. 130 
aeruginosa reference strain PAO1 (RefSeq accession number: NC_002516.2) using the 131 
Bowtie2 software (v2.2.4, http://bowtie-bio.sourceforge.net/bowtie2/index.shtml) (26). 132 
Pileups and raw files of the mapped reads were obtained by using the SAMtools 133 
(v.0.1.16, https://sourceforge.net/projects/samtools/files/samtools/) (27) and the 134 
PicardTools (v1.140, https://github.com/broadinstitute/picard). Read alignments 135 
surrounding all putative InDels were realigned using GATK (v3.4-46, 136 
https://www.broadinstitute.org/gatk/) (28). The list of Single Nucleotide Polymorphisms 137 
(SNPs) were obtained from the raw files meeting the following criteria: a quality score 138 
>50, a root-mean-square (RMS) mapping quality >25 and a coverage depth > 3; 139 
moreover, we checked manually all the positions in which at least one of the isolates 140 
differs from P. aeruginosa PAO1 in all the others raw files without any filtering. InDels 141 
were extracted from the total pileup files using the following criteria: a quality score 142 
>250, a RMS mapping quality >25 and a coverage depth >3.  143 
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 De novo assembly and phylogenetic analysis. Genomes from all isolates were 144 
de novo assembled using the de Bruijn graph-based assembler Velvet (v1.2.10, 145 
https://www.ebi.ac.uk/~zerbino/velvet/) (29). The 'velveth' command was executed 146 
using a k-mer size of 31 and the 'velvetg' command was run using the following 147 
parameters: scaffolding = no, ins_length = 500, cov_cutoff = 3 and  min_contig_lgth = 148 
500. The size range of the de novo assembled genomes was 4.9-6.9 Mbp, and each 149 
genome shared 93.5-96.9 % of the content of the P. aeruginosa reference strain PAO1.  150 
The de novo assembled genomes were aligned against each other using parSNP from 151 
the Harvest Suite package (v1.2, 152 
http://harvest.readthedocs.io/en/latest/content/parsnp.html) (30) and a core-genome 153 
phylogeny tree was obtained and displayed with FigTree. The default parameters 154 
recommended by the program were followed during the whole analysis. SNP 155 
differences among isolates were calculated from the lists of SNP previously obtained, 156 
excluding all common and ambiguous positions.  157 
 BEAST analysis. Bayesian analysis of divergence times was performed using 158 
BEAST (v2.4.2, http://beast2.org/) (31). For this purpose a nexus file was constructed 159 
including all the positions in which at least one of the isolates differs from the P. 160 
aeruginosa reference strain PAO1, and converted into an .xml file with BEAUTi. These 161 
positions fulfilled the criteria used to calculate the SNP distances among isolates. 162 
BEAST was run under the following user-determined settings; a lognormal relaxed 163 
molecular clock model and a general time-reversible substitution model with gamma 164 
correction (32). Results were produced from one chain with 50 million steps, sampled 165 
every 1000 steps. The first 5 million steps were discarded as a burn-in. The maximum 166 
clade credibility tree was generated (using TreeAnnotator program from BEAST 167 
package), and displayed using FigTree (v1.4.2, 168 
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http://tree.bio.ed.ac.uk/software/figtree/). Tree parameters were calculated by Tracer 169 
(v1.6, http://beast.bio.ed.ac.uk/Tracer). 170 
 Antibiotic resistance genes profiling. Based on literature review we established 171 
a set of 146 genes known to be related with antibiotic resistance mechanisms in P. 172 
aeruginosa, in order to correlate the documented resistance genotypes with the observed 173 
resistance phenotypes. SNP and InDels were annotated by using the snpEff software 174 
(v4.2, http://snpeff.sourceforge.net/index.html) (33) with the default options, and the 175 
output file containing the nucleotidic changes and the predicted effect at protein level 176 
were analyzed. Finally we used the on-line Comprehensive Antibiotic Resistance Data 177 
Base (CARD, v3.1.1, https://card.mcmaster.ca/home) (34) to complete the analysis, and 178 
the online tool Resfinder (v2.1, https://cge.cbs.dtu.dk//services/ResFinder/) (35) in order 179 
to identify horizontally-acquired antimicrobial resistance genes. 180 
 Nucleotide sequence accession numbers. Sequence files were deposited in the 181 
European Nucleotide Archive under study number ERP016726 and accession numbers 182 
ERS1280254 to ERS1280271 and ERS1280273 to ERS1280276. 183 
184 
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Results and discussion 185 
Phylogenetic analysis of ST175 isolates. A total of 453 high-quality SNPs were 186 
detected among ST175 isolates using PAO1 genome as reference. Accordingly, ST175 187 
isolates differed from each other in 18 to 168 SNPs. As shown in Figure 1, the four 188 
French isolates clustered together with the two isolates from one of the Spanish regions 189 
(Cantabria). In some of the cases, but not always, both studied isolates from a single 190 
hospital clustered closely (e.g. isolates from hospitals 1 and 5). BEAST analysis (Figure 191 
2) indicated that all the isolates were linked by a common ancestor from approximately 192 
25 years ago (1990s). 193 
ST175 resistome. The complete list of genes investigated and the variations 194 
detected in each of the 22 studied isolates is reported in Table S1; Table 1 shows the list 195 
of genes showing nonsynonymous SNPs and the number of isolates involved; insertions 196 
or deletions were not detected in any of the genes. Up to 83 (56.8%) of the 146 genes 197 
showed nonsynonymous SNPs in at least one of the studied isolates. Of those genes, 55 198 
(66.3%) showed the same nonsynonymous SNPs in all 22 studied isolates, 23 (25.3%) 199 
showed SNPs in just one of the isolates and 5 (6.0%) showed SNPs in at least 2 (but not 200 
all) of the studied isolates. 201 
Table 2 shows the MICs obtained for the panel of antibiotics tested and a 202 
selection of the main mutations and genes known or expected to be involved in the 203 
resistance profiles, mainly including penicillin-β-lactamase inhibitor combinations, 204 
cephalosporins, monobactams, carbapenems, aminoglycosides (gentamicin and 205 
tobramycin), and fluoroquinolones. 206 
AmpC-driven resistance. All except one (PAmb75) of the 22 studied isolates 207 
showed ampC overexpression (mean 263.6 ± 215.8-fold higher respect wild-type 208 
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PAO1). ampC overexpression correlated well with ceftazidime and piperacillin-209 
tazobactam resistance, except for isolate PAmb258 (from the  bloodstream infections 210 
multicenter study) which was susceptible to these antibiotics. A possible explanation is 211 
the presence of a nonsense mutation in mexA (Q183X), component of the constitutive 212 
efflux pump MexAB-OprM, well known to play a major role in intrinsic resistance to 213 
many antibiotics including most β-lactams (36). Consistently with this observation, 214 
isolate PAmb258 showed also increased susceptibility to aztreonam and cefepime. 215 
Regarding the genetic basis of ampC overexpression, all of the 14 isolates from the 216 
bloodstream infections multicenter study contained the G154R ampR mutation 217 
previously demonstrated to cause the hyperproduction of AmpC (18). Moreover, the 218 
ampR mutation was also evidenced in the four recent isolates from Hospital Son 219 
Espases, and in 2 of the 4 French ST175 isolates. The other 2 French isolates, also 220 
showing ampC overexpression, contained a nonsynonymous mutation in ampD. 221 
Moreover, 2 isolates from the bloodstream infections multicenter study showed and 222 
additional nonsynonymous SNPs in ampD or dacB (PBP4). Additionally, as shown in 223 
Table 1, all 22 isolates shared nonsynonymous SNPs in genes recently related to ampC 224 
expression and β-lactam resistance such as nuoG, mltB1, mltD, creB, creC or creD (37, 225 
38, 39), but in all cases these SNPs were documented in other available P. aeruginosa 226 
genomes suggesting that they are natural polymorphism not involved in resistance 227 
(www.pseudomonas.com). However, the role in ampC expression and β-lactam 228 
resistance of unique nonsynonimous SNPs in sltB1, creB, creC, ampP or ampG, 229 
detected in single isolates (Table 1), needs to be explored in future studies.  230 
Role of porins. Carbapenem resistance correlated well with the presence of 231 
nonsense mutations in oprD (encoding the porin for basic aminoacids and carbapenems 232 
OprD), evidenced in all isolates except the single one that was imipenem susceptible 233 
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(Table 2). All imipenem resistant Spanish isolates, and one of the French isolates, 234 
contained the previously described Q142X mutation in oprD (18); the 3 remaining 235 
French isolates showed an alternative oprD mutation, W138X. Low meropenem MICs 236 
were also seen in the isolate showing wild-type oprD sequence, and, in agreement with 237 
its substrate profile (36) in the isolate showing a nonsense mutation in mexA (Table 2).  238 
Finally, as shown in Table 1, a single isolate contained a nonsense mutation in the porin 239 
OprF, although its contribution to antimicrobial resistance is still uncertain (40). 240 
Contribution of PBP mutations to the resistance profile. Another potentially 241 
relevant target for β-lactam resistance are the PBPs. pbpC (PBP3A), ponA (PBP1A) and 242 
pbpG (PBP7) showed (the same) nonsynonimous SNPs in all 22 studied isolates (Table 243 
1) and thus they might just well be natural polymorphisms seen in ST175 lineage not 244 
affecting the function of these PBPs. Indeed, most of these SNPs were documented in 245 
other available P. aeruginosa genomes (www.pseudomonas.com). On the other hand, 246 
ftsI (PBP3) mutations emerged independently in three different ST175 isolates (Table 1, 247 
Table 2). These findings suggest that PBP3 is under strong mutational pressure, 248 
consistently with recent data showing that PBP3 mutations emerge frequently during the 249 
course of CF chronic infection (41). Likewise, recent studies show that PBP3 mutations 250 
emerge frequently upon meropenem exposure in vitro (42). The documented R504C 251 
mutation support these findings, since (i) it was detected in the isolate showing the 252 
highest level of resistance to meropenem, (ii) it is located close to the β-lactam binding 253 
site (43), and (iii) mutations in this precise residue have been shown to be selected upon 254 
meropenem exposure in vitro (42). However, the involvement of the other two 255 
mutations in resistance is less obvious, both at phenotypic and structural level. Finally, 256 
one isolate (PAmb440) showed a unique nonsynonymous substitution in PBP1B 257 
(R746H). The effect of this mutation still needs to be experimentally addressed, but it is 258 
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located in a highly conserved residue and is documented in the isolate showing overall 259 
highest resistance to cefalosporins, penicillins and monobactams (Table 2). The effect, 260 
if any, of a unique mutation in PBP5 documented in one of the isolates is uncertain 261 
(Table 2), although PBP5 has been shown to contribute to some extent through its role 262 
in AmpC induction, β-lactam trapping and/or β-lactamase activity (44, 45). 263 
Involvement of efflux pumps. Another major relevant aspect to consider when 264 
analyzing P. aeruginosa resistance profiles is the expression of efflux pumps. 265 
Interestingly, all 22 isolates showed the previously identified G195E substitution in 266 
MexZ (18). Indeed, this substitution has been previously demonstrated to be involved in 267 
MexXY overexpression (46), as seen in all studied isolates (12.9 ± 11.0-fold higher with 268 
respect to PAO1). According to existing literature, the unique mutations, found in single 269 
isolates, in ParS, AmgS or AmgR could also modulate MexXY expression (46). 270 
MexXY overexpression is well known to contribute to cefepime and aminoglycoside 271 
resistance (47), although the profiles documented for the latter agents are largely caused 272 
by aminoglycoside modifying enzymes (see below). The four French and two of the 273 
Spanish isolates showed nonsynonymous SNPs in mexX (W358R); whether this 274 
mutation affects the substrate profile needs to be further investigated.  As commented 275 
above, one isolate was found to harbor a nonsense mutation in mexA, associated with 276 
hypersusceptibility to most β-lactams due to the impairment of MexAB-OprM efflux 277 
pump. On the other hand, all 22 studied isolates showed two nonsynonimous mutations 278 
the MexAB-OprM regulator nalC (G71E and A186T) (Table 1). However, these 279 
substitutions are likely polymorphisms because they are frequent among diverse 280 
available P. aeruginosa genomes (www.pseudomonas.com) and because overall mexB 281 
expression was not much different among ST175 isolates compared to wild-type PAO1 282 
(2.4±1.4). Finally, a number of isolates showed unique or common substitutions in other 283 
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efflux pump components, including MexCD-OprJ or MexEF-OprN (Table 1), but 284 
overexpression of either efflux pumps was not documented in any of the isolates (not 285 
shown).  286 
Mutations leading to fluoroquinolone resistance. All eighteen Spanish isolates 287 
studied showed high-level fluoroquinolone resistance (ciprofloxacin MICs 32-128 288 
mg/L) and contained 3 previously described QRDR mutations: T83I and D87N in gyrA 289 
and S87W in parC. However, the four French isolates showed a slightly lower 290 
resistance level (ciprofloxacin MICs 8-16 mg/L) and lacked the D87N mutation in gyrA 291 
(Table 2). 292 
Horizontally acquired resistance elements-aminoglycoside modifying 293 
enzymes. The presence of horizontally-acquired resistance determinants was explored 294 
through PCR amplification of the most relevant ESBL and carbapenemase genes and by 295 
using the Resfinder tool on WGS. While genes coding for horizontally-acquired β-296 
lactamases were ruled out in all the strains, the 22 isolates harbored an aadB gene 297 
coding for an adenyltransferase previously shown to be responsible of the 298 
aminoglycoside resistance profile (resistant to gentamicin and tobramycin and 299 
susceptible to amikacin) of ST175 isolates (18). Moreover,the four French isolates and 300 
the 2 isolates from one of the Spanish regions (Cantabria) harbored and additional 301 
adenyltransferase gene aadA13, known to be involved in streptomycin resistance (48). 302 
Indeed, streptomycin MICs in isolates positive for aadA13 were >64 mg/L whereas in 303 
those lacking this gene the MIC were ≤8 mg/L. In all isolates aad genes were located in 304 
a class 1 integron, containing either aadB alone or both aadB and aadA13. 305 
Mechanisms of fosfomycin resistance. All studied isolates except the four 306 
French isolates and the two isolates from Cantabria showed a nonsynonimous SNP 307 
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(T211P) in glpT, coding for a glycerol-3-phospate permease known to be involved in P. 308 
aeruginosa fosfomycin resistance (49). Indeed, as shown in Table 2, the presence of the 309 
mutation was associated with extremely high fosfomycin MICs (>1024 mg/L) whereas 310 
those strains lacking the mutation showed much lower MICs (8-16 mg/L).  311 
Concluding remarks. In the last few years WGS has consolidated as a highly 312 
useful tool for the investigation of the molecular epidemiology and genetic basis of 313 
resistance in MDR pathogens, including P.aeruginosa. For instance, Kos et al have 314 
recently analyzed the correlation between the resistome and the phenotype of resistance 315 
to three antibiotics in a large collection of diverse P. aeruginosa strains (50). Likewise, 316 
a recent study by Turton et al have used WGS to analyze the molecular epidemiology 317 
and evolution of the MDR/XDR MBL-producing high-risk clone ST111 in UK (51). In 318 
this work we have analyzed through WGS the molecular epidemiology and the 319 
resistome of the international MDR/XDR high-risk clone ST175. Indeed, the resistome 320 
of ST175 was found to be mainly determined by mutational events, with resistance 321 
traits ranging from those common to all (e.g. specific QRDR and mexZ mutations) or 322 
most (e.g. specific ampR and oprD mutations) of the studied isolates from Spain and 323 
France, to those found in certain geographic areas (e.g. glpT mutation) or unique strains 324 
(e.g. PBP3 mutations). Phylogenetic analysis revealed two distinct clades, one 325 
containing the isolates from France and Cantabria and the other one all remaining 326 
isolates from Spain; at least two clear resistance features separated the French-Cantabria 327 
clade from the other one, the presence of the streptomycin resistance gene aadA13 and 328 
the absence of a specific GlpT (fosfomycin resistance) mutation. Moreover, we 329 
analyzed the WGS available for the nine ST175 isolates from the Kos et al collection 330 
(50), recovered from Spain, France, Germany and Italy, and confirmed the existence of 331 
common and variable ST175 resistance mutations. Likewise, comparative genome 332 
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analysis of our isolates with that of a ST175 strain that produced a large outbreak in a 333 
hospital from Madrid (19, 52) revealed the same QRDR and mexZ mutations, despite in 334 
this case, instead of the β-lactam resistance mutations (oprD and ampR), the strain 335 
harbored a VIM-2 MBL. Thus, tracking down these mutations provides valuable 336 
information for understanding both, the genetic basis of resistance and the dynamics of 337 
dissemination and evolution of MDR/XDR strains. Much further work is however 338 
needed to understand the basis for the global success of this and other high-risk clones. 339 
Recent works have suggested that high-risk clones are associated with defined 340 
biological markers, including reduced fitness, motility (Swimming, swarming and 341 
twitching), and pigment production but increased biofilm formation and mutation rates 342 
(53). Thus, ongoing WGS analysis will add valuable data to correlate genotype with 343 
phenotype and to decipher the underlying factors driving the global success of high-risk 344 
clones. 345 
346 
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Legends 548 
Figure 1. Core-genome phylogenetic tree, based on SNPs analysis by default 549 
parameters of parSNPs. Isolates from the Spanish multicenter study are labeled by: 550 
Sample name-Hospital number (H1-H8)-city-year of isolation. French isolates are 551 
labeled by: Sample name – France – year of isolation. 552 
Figure 2. Bayesian evolutionary analysis sampling trees (BEAST) analysis of ST175 553 
isolates from Spain and France calculated using a relaxed molecular clock. Isolates from 554 
the Spanish multicenter study are labeled by: Sample name – Hospital number (H1-H8)-555 
city-year of isolation. French isolates are labeled by: Sample name – France – year of 556 
isolation. The horizontal position of isolates on the tree is according to the date of 557 
isolation. Calculated times for putative common ancestors (at the nodes) can be read 558 
from the scale (in years). Time zero is that of the most recent isolate (2015). 559 
 560 
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Table 1. Nonsynonymous SNPs detected for the 146 genes related to antibiotic resistance in the 
22 ST175 studied isolates using PAO1 as reference genome  
Gene 
Locus 
Name SNP (number of isolates) Gene 
Locus 
Name SNP (number of isolates) 
PA0018 fmt S54N (22) PA2642 nuoG A433T (22), T484A (22) 
PA0058 dsbM G32C (22) PA2798  S280C (22), E297D (22), G301S (22), T317S (22), S353L (22) 
PA0425 mexA Q183X (1) PA2809 copR F25L (1) 
PA0426 mexB V45L (1) PA2810 copS N97S (22), R130Q (22) 
PA0427 oprM R404H (1) PA3047 dacB P59S (1) 
PA0463 creB E128G (22), N152T (1) PA3078 cprS I348M (1) 
PA0464 creC G157A (22), S437C (1), Q457L (22) PA3168 gyrA T83I (22), D87N (18) 
PA0465 creD V394A (22) PA3677 mexJ F13L (22) 
PA0486  D210E (22), D258E (22), L313Q (1) PA3678 mexL S4P (22) 
PA0487  R118C (1), H191Q (22) PA3721 nalC G71E (22), A186T (22) 
PA0610 prtN S4T (22), S8T (22) PA3999 dacC D308E (1) 
PA0611 prtR L16H (1), A75T (22), G251A (22) PA4001 sltB1 D225E (1) 
PA0807 ampDh3 A219T (22) PA4109 ampR G154R (19) 
PA0869 pbpG S250N (22) PA4119 aph A42V (22) 
PA0958 oprD Q142X (18), W138X (3) PA4207 mexI A561V (1), A603S (22) 
PA1343 pagP G149A (22) PA4218 ampP S329A (1) 
PA1345 gshB L17P (22), A460T (1) PA4270 rpoB V51I (22) 
PA1375 pdxB H71Q (1), Q365R (22) PA4381 colR D69Y (1) 
PA1409 aphA L62I (22), E236X (1) PA4393 ampG A583T (22) 
PA1777 oprF E149X (1) PA4418 ftsI W13R (1), D40V (1), R504C (1) 
PA1796 folD G159V (22) PA4444 mltB1 H64R (22), Q303R (22) 
PA1797  N171S (22), H195Y (22), L575Q (22) PA4462 rpoN R257W (1) 
PA1798 parS H398R (22) PA4522 ampD H77Y (2), T139M (1), G148A (22), N183Y (22) 
PA1799 parR E214D (1) PA4597 oprJ M69V (22), Y91X (1) 
PA1812 mltD T466P (22) PA4598 mexD E257Q (22), S845A (22), A963V  (1) 
PA1886 polB D176G (22) PA4599 mexC E26A (22), H310R (22), S330A (22), P383S (22) 
PA2006  E232Q (22) PA4700 mrcB R746H (1) 
PA2018 mexY T543A (22) PA4748 tpiA E21V (1) 
PA2019 mexX K329Q (22), W358R (7) PA4773  E21X (1) 
PA2020 mexZ G195E (22) PA4774  H208N (1) 
PA2023 galU K274N (1) PA4777 pmrB Y345H (22), M356T (1) 
PA2050  C142G (22) PA4964 parC S87W (22), L168Q (22) 
PA2272 pbpC E37K (22), A104P (22) PA5000 wapR T85A (22) 
PA2489  A244T (22) PA5038 aroB V85A (22), A200E (22) 
PA2490  T48S (22), R104C (22) PA5045 ponA E245D (22) 
PA2491 mexS D249N (22) PA5199 amgS R389S (1) 
PA2492 mexT P60S (22), F172I (22) PA5200 amgR Q180X (1) 
PA2494 mexF S65Y (1), L799V (1), T1003S (1) PA5235 glpT T211P (16) 
PA2525 opmB S139R (1), N311K (1), P495S (22) PA5297 poxB N243T (1) 
PA2526 muxC D716N (1) PA5366 pstB Q20H (1) 
PA2528 muxA T261A (22), V420M (22) PA5471 armZ L88P (22), D161G (22), H182Q (22), V243A (22), V266M (22) 
PA2615 ftsK S52P (22), S287P (22), G729S (22)    
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Taďle Ϯ. SusĐeptiďilitǇ pƌofiles aŶd aŶtiďiotiĐ ƌesistaŶĐe geŶes aŶd ŵutatioŶs deteĐted iŶ the studied ĐolleĐtioŶ of STϭϳϱ isolates. 
StraiŶ 
MICa ampC 
hǇperproduĐtioŶď oprD PBPs
ď MeǆAB/XY-OprMď QRDR glpT 
AŵiŶoglǇĐoside 
ModifǇiŶg 
EŶzǇŵes 
CA) 
;S≤8Ϳ 
FEP 
;S≤8Ϳ 
A)T 
;S≤8Ϳ 
PTz 
;S≤ϭ6Ϳ 
IMI 
;S≤4Ϳ 
MER 
;S≤4Ϳ 
GEN
;S≤4Ϳ 
TOB
;S≤4Ϳ 
AMK
;S≤ϭ6Ϳ 
LEV
;S≤ϮͿ 
CIP
;S≤ϭͿ 
COL
;S≤ϮͿ FOS 
PAŵďϭϮ ϭϲ ϭϲ ϭϲ ϯϮ ϭϲ ϭϲ >ϲϰ ϭϲ ϰ ϲϰ ϯϮ Ϭ.ϭϮϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX - meǆZ;GϭϵϱEͿ gǇrA ;TϴϯI, DϴϳNͿ + parC ;SϴϳWͿ TϮϭϭP aadB 
PAŵďϮϳ ϲϰ ϭϮϴ ϯϮ ϲϰ ϴ ϲϰ >ϲϰ ϯϮ Ϯ ϭϮϴ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX PBPϯ ;RϱϬϰCͿ 
ŵeǆB ;VϰϱLͿ 
+  
ŵeǆ) 
;GϭϵϱEͿ 
gǇrA ;TϴϯI, DϴϳNͿ + 
parC ;SϴϳWͿ TϮϭϭP aadB 
PAŵďϰϯ ϲϰ ϯϮ ϭϲ ϭϮϴ ϯϮ ϭϲ >ϲϰ ϯϮ ϰ ϭϮϴ ϲϰ Ϭ.ϱ ϭϲ ampR ;GϭϱϰRͿ + ampD ;TϭϯϵMͿ QϭϰϮX - meǆZ ;GϭϵϱEͿ 
gǇrA ;TϴϯI, DϴϳNͿ + 
parC ;SϴϳWͿ - aadB + aadA13 
PAŵďϳϱ ϰ ϭϲ ϭϲ ϭϲ Ϭ.ϱ ϭ >ϲϰ ϯϮ ϰ ϭϮϴ ϲϰ Ϭ.Ϯϱ ϭϲ - - - meǆZ;GϭϵϱEͿ gǇrA ;TϴϯI, DϴϳNͿ + parC ;SϴϳWͿ - aadB + aadA13 
PAŵďϵϯ ϲϰ ϯϮ ϯϮ ϭϮϴ ϭϲ ϭϲ >ϲϰ ϯϮ ϰ ϭϮϴ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX - 
meǆX
;WϯϱϴRͿ + 
meǆZ 
;GϭϵϱEͿ 
gǇrA ;TϴϯI, DϴϳNͿ + 
parC ;SϴϳWͿ TϮϭϭP aadB 
PAŵďϭϮϯ ϯϮ ϯϮ ϯϮ ϭϮϴ ϭϲ ϯϮ >ϲϰ ϯϮ ϰ Ϯϱϲ ϭϮϴ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ +  dacB ;PϱϵSͿ QϭϰϮX - meǆZ;GϭϵϱEͿ gǇrA ;TϴϯI, DϴϳNͿ + parC ;SϴϳWͿ TϮϭϭP aadB 
PAŵďϭϰϳ ϯϮ ϯϮ ϭϲ ϲϰ ϯϮ ϭϲ >ϲϰ ϭϲ ϰ ϭϮϴ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX - meǆZ;GϭϵϱEͿ gǇrA ;TϴϯI, DϴϳNͿ + parC ;SϴϳWͿ TϮϭϭP aadB 
PAŵďϭϳϵ ϯϮ ϯϮ ϭϲ ϭϮϴ ϯϮ ϭϲ >ϲϰ ϯϮ ϰ ϭϮϴ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX - meǆZ;GϭϵϱEͿ gǇrA1 ;TϴϯI, DϴϳNͿ + parC ;SϴϳWͿ TϮϭϭP aadB 
PAŵďϭϵϯ ϯϮ ϭϲ ϭϲ ϲϰ ϭϲ ϴ >ϲϰ ϯϮ ϰ ϭϮϴ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX PBPϱ ;DϯϬϴEͿ 
meǆD
;AϵϲϯVͿ + 
meǆZ 
;GϭϵϱEͿ 
gǇrA ;TϴϯI, DϴϳNͿ + 
parC ;SϴϳWͿ TϮϭϭP aadB 
PAŵďϮϬϳ ϯϮ ϭϲ ϭϲ ϲϰ ϭϲ ϭϲ >ϲϰ ϯϮ ϰ ϭϮϴ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX - meǆZ;GϭϵϱEͿ gǇrA ;TϴϯI, DϴϳNͿ + parC ;SϴϳWͿ TϮϭϭP aadB 
PAŵďϮϱϴ ϰ ϰ Ϯ ϴ ϯϮ ϭ >ϲϰ ϭϲ ϰ ϯϮ ϯϮ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX PBPϯ ;WϭϯRͿ 
meǆA
;QϭϴϯXͿ + 
meǆZ 
;GϭϵϱEͿ 
gǇrA ;TϴϯI, DϴϳNͿ + 
parC ;SϴϳWͿ TϮϭϭP aadB 
PAŵďϰϰϬ ϭϮϴ ϲϰ ϲϰ Ϯϱϲ ϯϮ ϴ >ϲϰ ϯϮ ϰ ϭϮϴ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX PBPϭB ;RϳϰϲHͿ 
meǆX
;WϯϱϴRͿ + 
meǆZ 
;GϭϵϱEͿ 
gǇrA ;TϴϯI, DϴϳNͿ + 
parC ;SϴϳWͿ TϮϭϭP aadB 
PAŵďϰϴϮ ϯϮ ϯϮ ϭϲ ϭϮϴ ϲϰ ϯϮ >ϲϰ ϯϮ ϰ ϭϮϴ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX PBPϯ;DϰϬVͿ meǆZ;GϭϵϱEͿ gǇrA ;TϴϯI, DϴϳNͿ + parC ;SϴϳWͿ TϮϭϭP aadB 
PAŵďϱϭϲ ϯϮ ϴ ϴ ϭϲ ϴ ϰ >ϲϰ ϯϮ ϰ ϭϮϴ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX - meǆZ;GϭϵϱEͿ gǇrA ;TϴϯI, DϴϳNͿ + parC ;SϴϳWͿ TϮϭϭP aadB 
HUSE_FϬϮϴ ϲϰ ϭϲ ϯϮ ϭϮϴ ϭϲ ϭϲ >ϲϰ ϭϲ ϰ ϲϰ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX - 
oprM
;RϰϬϰHͿ + 
meǆZ 
;GϭϵϱEͿ 
gǇrA ;TϴϯI, DϴϳNͿ + 
parC ;SϴϳWͿ TϮϭϭP aadB 
HUSE_FϬϯϰ ϲϰ ϯϮ ϯϮ Ϯϱϲ ϲϰ ϯϮ >ϲϰ ϭϲ Ϯ ϲϰ ϯϮ Ϭ.ϭϮϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX - 
meǆX
;WϯϱϴRͿ + 
meǆZ 
;GϭϵϱEͿ 
gǇrA ;TϴϯI, DϴϳNͿ + 
parC ;SϴϳWͿ TϮϭϭP aadB 
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HUSE_FϬϯϲ ϭϲ ϭϲ ϭϲ ϲϰ ϲϰ ϭϲ >ϲϰ ϯϮ ϰ ϭϮϴ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX  meǆZ;GϭϵϱEͿ gǇrA ;TϴϯI, DϴϳNͿ + parC ;SϴϳWͿ TϮϭϭP aadB 
HUSE_FϬϰϭ ϭϲ ϭϲ ϭϲ ϲϰ ϲϰ ϭϲ >ϲϰ ϯϮ ϰ ϭϮϴ ϲϰ Ϭ.ϱ >ϭϬϮϰ ampR ;GϭϱϰRͿ QϭϰϮX - meǆZ;GϭϵϱEͿ gǇrA ;TϴϯI, DϴϳNͿ + parC ;SϴϳWͿ TϮϭϭP aadB 
FRA_BOR ϴ ϴ ϴ ϯϮ ϯϮ ϭϲ >ϲϰ ϯϮ ϰ ϭϲ ϭϲ Ϭ.ϱ ϴ ampD ;HϳϳYͿ WϭϯϴX - 
meǆX
;WϯϱϴRͿ + 
meǆZ 
;GϭϵϱEͿ
gǇrA ;TϴϯIͿ +  
parC ;SϴϳWͿ - aadB + aadA13 
FRA_CLI ϴ ϴ ϴ ϲϰ ϯϮ ϭϲ >ϲϰ >ϯϮ ϰ ϴ ϴ Ϭ.ϱ ϭϲ ampD ;HϳϳYͿ WϭϯϴX - 
meǆX
;WϯϱϴRͿ + 
meǆZ 
;GϭϵϱEͿ
gǇrA ;TϴϯIͿ +  
parC ;SϴϳWͿ - aadB + aadA13 
FRA_DIJ ϭϲ ϴ ϴ ϲϰ ϯϮ ϴ >ϲϰ ϯϮ ϰ ϭϲ ϭϲ Ϭ.ϭϮϱ ϭϲ ampR ;GϭϱϰRͿ QϭϰϮX - 
meǆX
;WϯϱϴRͿ + 
meǆZ 
;GϭϵϱEͿ
gǇrA ;TϴϯIͿ +  
parC ;SϴϳWͿ - aadB + aadA13 
FRA_BES ϴ ϰ ϴ ϯϮ ϭϲ ϰ >ϲϰ ϭϲ ϰ ϭϲ ϭϲ Ϭ.ϱ ϴ ampR ;GϭϱϰRͿ WϭϯϴX - 
meǆX
;WϯϱϴRͿ + 
meǆZ 
;GϭϵϱEͿ
gǇrA ;TϴϯIͿ +  
parC ;SϴϳWͿ - aadB + aadA13 
a CA), Đeftazidiŵe; FEP, Đefepiŵe; ATM, aztƌeoŶaŵ; PTz, pipeƌaĐilliŶ-tazoďaĐtaŵ; IMI, iŵipeŶeŵ, MER, ŵeƌopeŶeŵ; GEN, geŶtaŵiĐiŶ; TOB, toďƌaŵǇĐiŶ; AMK, aŵikaĐiŶ; LEV, levofloǆaĐiŶ, CIP, ĐipƌofloǆaĐiŶ; COL, ĐolistiŶ; FOS, fosfoŵǇĐiŶ. 
ďEǆĐept foƌ the meǆZ GϭϵϱE suďstitutioŶ, ĐhaŶges ƌespeĐt PAOϭ seƋueŶĐes doĐuŵeŶted iŶ all ϮϮ isolates aƌe Ŷot iŶĐluded iŶ this taďle 
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